Clinical trial
Prospective, Multi-centre, Observational Trial Evaluating Outcomes of Immediate Breast Reconstruction Using an Implant and Acellular Dermal Matrix (SurgiMend) or Autologous Tissue
NCT02557906 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi-centre, Observational Trial Evaluating Outcomes of Immediate Breast Reconstruction Using an Implant and Acellular Dermal Matrix (SurgiMend) or Autologous Tissue
- Lead sponsor
- King's College London
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2014
- Completion date
- January 31, 2020
- Enrollment
- 209 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.